Skip to content

Aemetis, Inc. AMTX India Biodiesel — Intangible Impairment

Similar metrics at other companies

PTH
PTHSImpairment of intangible assets
$71.25K
Biodesix, Inc. logo
BDSXImpairment of intangible assets
$5K-93.2%
RCM Technologies logo
RCMTImpairment of intangible assets
$0-100%
Blackbaud logo
BLKBImpairment of intangible assets
$91.88M
Albany International Inc. logo
AINImpairment of intangible assets
$300K
Amplitech Group, Inc. logo
AMPGImpairment of intangible assets
$116.98K

Other financials

Income statement

See full
Revenue$54.6M+27.4%
Gross profit$2.8M+154%
Operating income-$6.3M+59.3%
Net income-$21.7M+11.5%
EPS (diluted)-$0.33+29.8%

Balance sheet

See full
Cash & equivalents$4.8M+861%
Total debt$101.8M+18.6%
Total equity-$321.1M-14.4%
Total assets$270.3M+4.0%

Cash flow

See full
Operating cash flow-$10.6M-6,698%
CapEx$6.5M+259%
Free cash flow-$17.1M-927%

Valuation

See full
Market cap$116.1M-12.6%
Enterprise value$213.07M-0.6%
P/S0.6×0.0×

Profitability

See full
Gross margin-1.6%-0.3pp
Operating margin-13.4%-3.2pp
Net margin-35.4%-1.4pp
FCF margin-18.2%+1.1pp

Returns & leverage

See full
Return on equity24.7%
Debt / equity-0.3×
Current ratio0.1×-0.1×

Where this comes from

Reported directly by Aemetis, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ImpairmentOfIntangibleAssetsFinitelived.

The official record: Aemetis, Inc.’s 10-K, filed March 16, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aemetis, Inc.'s india biodiesel — intangible impairment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aemetis, Inc.'s india biodiesel — intangible impairment?
Aemetis, Inc. (AMTX) reported india biodiesel — intangible impairment of $0 in Q4 2025.
What does india biodiesel — intangible impairment mean?
This metric reflects the non-cash charge recognized when the carrying value of a finite-lived intangible asset exceeds its fair value. It indicates a decline in the expected economic benefit of assets such as patents, licenses, or customer relationships. Frequent impairments may signal poor capital allocation or deteriorating market conditions for the segment's intellectual property.